CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes

Objective: Doxorubicin (DOX)-induced cardiotoxicity limits the application of DOX in cancer patients. Currently, there is no effective prevention or treatment for DOX-induced cardiotoxicity. The cellular repressor of E1A-stimulated genes (CREG1) is a cardioprotective factor that plays an important r...

Full description

Bibliographic Details
Main Authors: Dan Liu, Xiaoli Cheng, Hanlin Wu, Haixu Song, Yuxin Bu, Jing Wang, Xiaolin Zhang, Chenghui Yan, Yaling Han
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231724002714